Alysia Kern Lovgren, PhD

Clinical Genomics Scientist at Invitae
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Rachel Harte

Alysia is a great team member. She is a great collaborator and team player. She is detail oriented and is highly skilled in variant interpretation with many years of experience in the genetic testing field. I am very happy to have had the opportunity to work with her and I thoroughly recommend her as being a great asset to any team.

LinkedIn User

Alysia is a detailed oriented scientist with a passion for provided high quality results to patients undergoing genetic testing. She has years of experience in this field, and is focused, intelligent, and careful in her work. I know Alysia as a colleague, and she is an incredible team member to work with. She is a great communicator and documentarian. She is always calm and kind even under stress. I'm so glad that we were able to work together.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Clinical Genomics Scientist
      • Dec 2020 - Present

      Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices.

    • Research Services
    • 700 & Above Employee
    • Clinical Genomics Scientist, Analysis Team Lead
      • Apr 2018 - Nov 2020

      The Broad Institute of MIT and Harvard is a non-profit, academic research institution based in Cambridge, Massachusetts, focused on using genomic data to better understand human health and disease. We have developed new advances in genome sequencing and analysis technology that have allowed us to find the genetic changes at the root of the diseases of thousands of patients. The Broad’s research philosophy is centered on large-scale collaborative research and open data sharing. • Led a team of clinical genomic analysts for the Rare Genomes Project and the Broad Institute's Center for Mendelian Genomics • Analyzed whole exome and genome sequencing to discover new disease genes and identify causal variants in patients with rare genetic disease Show less

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Senior Scientist, Molecular Genetics Review Analyst
      • Dec 2013 - Jun 2017

      GeneDx was founded in 2000 by two scientists from the National Institutes of Health (NIH) to address the needs of patients and clinicians in diagnosing rare inherited disorders. Currently, GeneDx offers testing for more than 400 rare Mendelian disorders, and gene panels for inherited cardiac disorders, inherited cancer syndromes, neurological disorders, and mitochondrial disorders. In addition, GeneDx also offers Whole Exome Sequencing and whole genome chromosomal microarray testing. • Researched and classified genetic variants according to ACMG guidelines to assist in the diagnosis of rare inherited diseases for whole exome sequencing cases • Reviewed Next-gen and Sanger sequencing results for accuracy Show less

    • Certified Triathlon Coach and Strength and Conditioning Specialist
      • Jan 2010 - Dec 2016

      At Catalyst 3 Coaching, we strive to be the spark that will motivate and guide you to reach your goals faster and easier. You will train smarter and more efficient with personalized training plans developed with a combination of elite athletic experience and an understanding of sport science. • Provided expert coaching services to endurance athletes from beginners to Ironman competitors • Developed business strategies to drive client growth using various marketing channels At Catalyst 3 Coaching, we strive to be the spark that will motivate and guide you to reach your goals faster and easier. You will train smarter and more efficient with personalized training plans developed with a combination of elite athletic experience and an understanding of sport science. • Provided expert coaching services to endurance athletes from beginners to Ironman competitors • Developed business strategies to drive client growth using various marketing channels

    • United States
    • Writing and Editing
    • 1 - 100 Employee
    • Manuscript Editor
      • Feb 2010 - Dec 2013

      American Journal Experts (AJE) has helped hundreds of thousands of researchers overcome barriers to the often-difficult academic publishing process and participate in the global conversation in their fields. We believe that every researcher deserves a voice; our editors, translators, and formatters are researchers too, so we understand the importance of publication and partner with authors to get their research published in the best journals. • Edited papers in the fields of molecular biology, genetics, cancer, immunology, virology, and pulmonary disease to help non-native English speakers publish in high-impact journals • Handled tight timelines in a business that depends on accuracy and strong technical writing skills Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Research Associate, Pulmonary Department
      • 2007 - 2010

      • Investigated the role of beta-arrestins and TLR signaling adapters in the development of pulmonary fibrosis and acute lung injury • Research findings led to the filing of a provisional patent titled: "A Novel Therapeutic for the Treatment of Idiopathic Pulmonary Fibrosis" and licensing to a NC biotech company. • Investigated the role of beta-arrestins and TLR signaling adapters in the development of pulmonary fibrosis and acute lung injury • Research findings led to the filing of a provisional patent titled: "A Novel Therapeutic for the Treatment of Idiopathic Pulmonary Fibrosis" and licensing to a NC biotech company.

Education

  • University of North Carolina at Chapel Hill
    Doctor of Philosophy (PhD), Genetics and Molecular Biology
    2002 - 2007
  • University of North Florida
    Bachelor of Science (B.S.), Biology
    1997 - 2001

Community

You need to have a working account to view this content. Click here to join now